Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

After Makary's FDA exit, biopharma exhales: Signal Survey

When Endpoints Signal released the Q3 Biopharma Sentiment Index last week, it showed a level of industry optimism not seen in years. Behind the topline figure, one area of improvement really stood ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 27 October →